Oncology diagnostics is entering a new phase. Established methods are gaining new clinical applications, selected emerging tests are moving into defined use, and research frontiers are beginning to shape the next wave of IVD innovation. Across risk assessment, early detection, tumour characterisation, treatment and follow-up, the question is no longer only what diagnostics can detect,…